These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 21512760

  • 1. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK, Marcus SN, Triadafilopoulos G.
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [Abstract] [Full Text] [Related]

  • 2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G.
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
    Ribolsi M, Cicala M, Zentilin P, Neri M, Mauro A, Efthymakis K, Petitti T, Savarino V, Penagini R.
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
    Savarino E, Zentilin P, Mastracci L, Dulbecco P, Marabotto E, Gemignani L, Bruzzone L, de Bortoli N, Frigo AC, Fiocca R, Savarino V.
    J Gastroenterol; 2013 Apr; 48(4):473-82. PubMed ID: 23001252
    [Abstract] [Full Text] [Related]

  • 6. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R, Gyawali CP, Pandolfino JE, CGIT GERD Consensus Conference Participants.
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL, Peng S, Tao J, Wang AJ, Lin JK, Hu PJ, Chen MH.
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [Abstract] [Full Text] [Related]

  • 10. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A, Jechorek D, Caro C, Weigt J, Wex T, Mönkemüller K, Malfertheiner P.
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
    Miyamoto M, Manabe N, Haruma K.
    Intern Med; 2010 Sep; 49(15):1469-76. PubMed ID: 20686276
    [Abstract] [Full Text] [Related]

  • 12. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
    Triadafilopoulos G, Kamal A, Clarke JO.
    Dis Esophagus; 2023 Jul 03; 36(7):. PubMed ID: 36567531
    [Abstract] [Full Text] [Related]

  • 13. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S.
    Neurogastroenterol Motil; 2014 Jan 03; 26(1):28-35. PubMed ID: 23992024
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M, Conigliaro R, Mirante VG, Melotti G.
    Neurogastroenterol Motil; 2012 Feb 03; 24(2):141-6, e87. PubMed ID: 21988704
    [Abstract] [Full Text] [Related]

  • 16. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study.
    Luo X, Guo XX, Wang WF, Peng LH, Yang YS, Uedo N.
    World J Gastroenterol; 2016 Apr 14; 22(14):3845-51. PubMed ID: 27076770
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
    Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M.
    J Gastroenterol; 2015 Mar 14; 50(3):298-304. PubMed ID: 24919745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.